General information, not medical advice or an insurance coverage decision. MedraxDME operates as an out of network supplier. Coverage, supplier enrollment requirements and patient responsibility depend on the plan and an individual review.
The product and the benefit are different things
A CGM is a medical device. Its classification in a particular insurance benefit determines who processes the request, which documentation is needed and where it may be dispensed. The word “prescription” does not automatically mean a pharmacy benefit, and the word “equipment” does not mean every plan uses the same medical benefit route.
Dexcom explains that some patients have pharmacy coverage while others receive supplies from an insurance designated distributor. Dexcom: Pharmacy and distributor access. That is a reason to ask about your exact plan, not a promise that both routes are interchangeable or available to every person.
Start by identifying the complete product name and your current plan. A benefits representative can then address a specific request. Asking only whether the insurer covers “a sensor” may lead to a general answer that misses the brand, model, benefit channel or designated supplier requirement that matters in your case.
What the medical equipment route can involve
Under a DME route, the supplier may need a valid order, supporting clinical records, benefit confirmation and any required authorization before arranging supplies. Each plan has its own requirements, and the applicable policy should be checked for the actual item and date.
For Original Medicare, qualifying CGMs and their supplies are covered under Part B's DME benefit, subject to the published criteria. The equipment must also meet the durable receiver or qualifying pump display requirements described in the CMS policy article. Medicare: Continuous glucose monitor coverage and CMS: Glucose Monitor policy article A52464.
Ask the supplier what it has already received and what is missing. If the answer is a clinical record, identify the treating office responsible for it. If it is an authorization, ask which organization requested it and whether a decision exists. This makes the process understandable without asking a patient to become a billing specialist.
What the pharmacy route can involve
With a pharmacy benefit, the plan or pharmacy benefits manager can identify a participating pharmacy, the covered product and any authorization or quantity requirements. A prescription may need to be sent to a particular pharmacy for processing. Do not assume that any pharmacy can obtain payment simply because it can receive the order.
Ask the plan to identify the exact product and explain whether the sensor, display device and other components follow the same route. If the pharmacy reports a rejection, ask whether it concerns coverage, authorization, timing, product identification or the dispensing location. A vague message can hide a correctable routing problem.
The pharmacy route for one diabetes product should not be applied automatically to another. Omnipod 5 is a useful example: Insulet identifies its Medicare access through Part D, while a person's separate CGM may be reviewed through another benefit. Insulet: Omnipod and Medicare Part D. Keep the pump and CGM requests clearly distinguished.
Network access and patient responsibility still matter
The insurer's name alone does not identify the network or benefits of every plan it offers. HealthCare.gov explains that plan types differ in their treatment of providers outside the network. HealthCare.gov: Plan and network types. A covered product can still have restrictions on which organization supplies it.
Ask the plan to confirm the particular dispensing organization and any patient responsibility before proceeding. Clarify whether an authorization addresses medical necessity only or also confirms the supply route. Keep the answer or reference number for later questions. Do not interpret a website's nationwide service area as evidence of an insurance contract.
MedraxDME identifies itself as an out of network supplier and reviews requests individually. The public site does not promise coverage under every medical or pharmacy benefit. If the plan requires a different organization, ask for the correct route rather than assuming that a callback submission creates an exception.
Avoid sending an order to the wrong channel
Before the clinician sends a prescription, ask which organization should receive it and whether that organization needs a specific form or additional records. Keep a clear contact for the prescribing office and the dispensing organization. If the request must move to another route, ask who will coordinate that change.
Do not send simultaneous requests to several organizations without explaining the situation. Multiple active requests can create uncertainty about who is arranging the supplies and which supply period is intended. A status note that names the current responsible organization is more useful than a list of every place you have called.
If a plan says “medical benefit” while a pharmacy says “not covered,” the answers may refer to different channels rather than disagreeing about whether CGM is ever covered. Ask the insurer to resolve that distinction explicitly. Conversely, do not assume that a medical supplier's inability to bill means the pharmacy benefit will automatically approve the product.
Recheck when the plan or equipment changes
A new plan year, employer change, Medicare enrollment change or new device can affect the applicable route. A product that was dispensed through one organization previously may need a fresh review. Tell your prescribing and dispensing teams before the next supply is arranged if your insurance or prescription changes.
Do not cancel a current supply route simply because a new inquiry is open. Confirm the new arrangement, required records and intended timing first. If a delay affects your monitoring, discuss the care plan with your clinician instead of relying on an assumed delivery date.
Keep a private transition list: current organization, proposed organization, exact model, prescription status, benefit decision and next action. Do not include that information in public website comments. If you need to share medical or insurance details, use the appropriate secure channel arranged by the organization handling the review.
A short script for a useful benefits call
You can ask: “My clinician is considering this exact CGM model. Does my current plan handle it through a medical equipment benefit or pharmacy benefit? Which dispensing organizations can serve that benefit? What authorization and documentation are required? What responsibility would I have, and who can confirm that before supply?”
Then repeat the answer in your own words and ask the representative to correct any misunderstanding. Record the date and reference number. Ask where to find the relevant plan document or policy. This gives the clinician and receiving organization a clearer starting point than an unqualified statement that a brand is covered.
If different representatives give conflicting answers, ask which benefit team can provide the controlling plan document. Keep the question focused on the same prescribed product and plan year so that the answers can be compared meaningfully.
MedraxDME's callback form is a starting point. Do not submit an insurance card, member number or clinical history there. For more context, read the network guide and explore the diabetes catalog to identify the prescribed product accurately.
Questions and answers
Does a prescription always mean the pharmacy benefit?
No. DME also requires an appropriate prescription or order. The plan determines the applicable benefit and dispensing route for the exact item.
Can the pump and CGM use different benefits?
Yes. Check each prescribed component separately. A benefit decision for one product does not automatically apply to another connected product.
Can I choose any supplier if the CGM is covered?
Not necessarily. Network, enrollment, authorization and designated supplier rules can still apply. Confirm the exact organization with your plan.
Sources and updates
- Dexcom: Pharmacy and distributor access
- Medicare: Continuous glucose monitor coverage
- CMS: Glucose Monitor policy article A52464
- Insulet: Omnipod and Medicare Part D
- HealthCare.gov: Plan and network types
- CMS: Standard Documentation Requirements A55426
Read our editorial and correction policy. For current plan rules, check the applicable official policy and contact your plan. Tell us about a correction.